Page last updated: 2024-09-05

sb 203580 and Neuromuscular Diseases

sb 203580 has been researched along with Neuromuscular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, J; Wong, PK	1

Other Studies

1 other study(ies) available for sb 203580 and Neuromuscular Diseases

Article	Year
Targeting p38 mitogen-activated protein kinase signaling restores subventricular zone neural stem cells and corrects neuromotor deficits in Atm knockout mouse. Stem cells translational medicine, 2012, Volume: 1, Issue:7 Topics: Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mice, Knockout; Neural Stem Cells; Neuromuscular Diseases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Purkinje Cells; Pyridines; Tumor Suppressor Proteins	2012

Article

Year

Targeting p38 mitogen-activated protein kinase signaling restores subventricular zone neural stem cells and corrects neuromotor deficits in Atm knockout mouse.

Stem cells translational medicine, 2012, Volume: 1, Issue:7

Topics: Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mice, Knockout; Neural Stem Cells; Neuromuscular Diseases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Purkinje Cells; Pyridines; Tumor Suppressor Proteins

2012